Targeting the COMMD4-H2B protein complex in lung cancer.
Ming TangJoshua T BurgessMark FisherDidier BoucherEmma BoldersonNeha S GandhiKenneth J O'ByrneDerek J RichardAmila SuraweeraPublished in: British journal of cancer (2023)
Our data shows that COMMD4-H2B represents a novel potential NSCLC therapeutic target.